Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
5,906,388
-
Shares change
-
+1,479,665
-
Total reported value, excl. options
-
$82,511,505
-
Value change
-
+$20,938,872
-
Put/Call ratio
-
1.26%
-
Number of buys
-
49
-
Number of sells
-
-13
-
Price
-
$13.97
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2023
79 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,906,388 shares
of 26,475,256 outstanding shares and own 22.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,205,832 shares), PURA VIDA INVESTMENTS, LLC (798,922 shares), BlackRock Inc. (482,797 shares), MILLENNIUM MANAGEMENT LLC (335,476 shares), EAM Investors, LLC (255,024 shares), GEODE CAPITAL MANAGEMENT, LLC (250,059 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (230,077 shares), RENAISSANCE TECHNOLOGIES LLC (212,336 shares), Invesco Ltd. (151,494 shares), and JANE STREET GROUP, LLC (140,851 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.